J. GOLDMAN & CO LP – Neurocrine Biosciences, Inc. Transaction History
J. GOLDMAN & CO LP portfolio value:
$4.82M
portfolio value
J. GOLDMAN & CO LP quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +498.96% | 37.83K shares | 4.08M | $106.21 | 45.41K |
| Q2 2022 | share | Increase | 0.00% | 7.58K shares | 739K | $97.48 | 7.58K |
| Q2 2022 | call | Decrease | -100.00% | -6.8K shares | -638K | $97.48 | 0 |
| Q1 2022 | call | Increase | 0.00% | 6.8K shares | 638K | $93.75 | 6.8K |
| Q2 2017 | share | Decrease | -100.00% | -46.7K shares | -2.02M | $46 | 0 |
| Q1 2017 | share | Increase | 0.00% | 46.7K shares | 2.02M | $43.3 | 46.7K |